This is a Validated Antibody Database (VAD) review about human HLA B, based on 38 published articles (read how Labome selects the articles), using HLA B antibody in all methods. It is aimed to help Labome visitors find the most suited HLA B antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HLA B synonym: AS; B-4901; HLAB

Invitrogen
mouse monoclonal (W6/32)
  • immunocytochemistry; human; fig s2d
  • flow cytometry; mouse; loading ...
Invitrogen HLA B antibody (Thermo-Fisher, MA5-11723) was used in immunocytochemistry on human samples (fig s2d) and in flow cytometry on mouse samples . J Exp Clin Cancer Res (2021) ncbi
mouse monoclonal (B1.23.2)
  • flow cytometry; human
Invitrogen HLA B antibody (Thermo Fisher Scientific, B1.23.2) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...
Invitrogen HLA B antibody (eBioscienc, 12-9983-42) was used in flow cytometry on human samples . Nat Commun (2020) ncbi
rat monoclonal (YTH862.2)
  • flow cytometry; human; loading ...; fig 3e
Invitrogen HLA B antibody (Invitrogen, MA1-80014) was used in flow cytometry on human samples (fig 3e). Breast Cancer Res (2019) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen HLA B antibody (eBioscience, W6/32) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (W6/32)
  • blocking or activating experiments; human; loading ...; fig s2b
Invitrogen HLA B antibody (eBiosciences, w6/32) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi
mouse monoclonal (BB7.1)
  • flow cytometry; human; loading ...; fig 3c
Invitrogen HLA B antibody (Thermo Scientific, MA1-82180) was used in flow cytometry on human samples (fig 3c). J Virol (2018) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...; fig 1a
In order to evaluate the effectiveness of adoptive natural killer cell therapy against the pulmonary metastasis of Ewing sarcoma, Invitrogen HLA B antibody (eBiosciences, W6/32) was used in flow cytometry on human samples (fig 1a). Oncoimmunology (2017) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...; fig 1a
In order to develop a recombinant Saccharomyces cerevisiae as a vehicle to deliver genes to primary human macrophages, Invitrogen HLA B antibody (eBioscience, W6/32) was used in flow cytometry on human samples (fig 1a). Eur J Pharm Biopharm (2017) ncbi
mouse monoclonal (W6/32)
  • immunohistochemistry; human; 1:5000; loading ...
In order to assess the diagnostic value of myxovirus resistance A expression for dermatomyositis, Invitrogen HLA B antibody (Thermo Fisher, W6/32) was used in immunohistochemistry on human samples at 1:5000. Neurology (2017) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...; fig s9a
Invitrogen HLA B antibody (eBiosciences, W6/32) was used in flow cytometry on human samples (fig s9a). PLoS Pathog (2016) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; fig 1
In order to analyze how Saccharomyces cerevisiae interacts with different macrophage subsets, Invitrogen HLA B antibody (eBioscience, W6/32) was used in flow cytometry on human samples (fig 1). Inflammation (2016) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; loading ...; fig s9a
In order to discuss how signal peptidase complex proteins affect flaviviruses, Invitrogen HLA B antibody (eBiosciences, W6/32) was used in flow cytometry on human samples (fig s9a). Nature (2016) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; 1:50; fig s2j
In order to develop and characterize a humanized ossicle xenotransplantation approach, Invitrogen HLA B antibody (ebioscience, W6/32) was used in flow cytometry on human samples at 1:50 (fig s2j). Nat Med (2016) ncbi
mouse monoclonal (W6/32)
  • immunohistochemistry - paraffin section; human; 1:5000; fig 4
In order to determine if there is an association between inclusion body myositis and hepatitis C virus infection, Invitrogen HLA B antibody (Thermo Fisher Scientific, W6/32) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 4). Neurology (2016) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; fig 6
In order to investigate the effect of SGI-110 on cancer testis antigen gene-regulated expression, Invitrogen HLA B antibody (eBioscience, clone W6/32) was used in flow cytometry on human samples (fig 6). Leuk Res (2014) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human
Invitrogen HLA B antibody (eBioscience, W6/32) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (W6/32)
  • immunoprecipitation; human
  • western blot; human
In order to study lactacystin and IFN-gamma in human salivary glands, Invitrogen HLA B antibody (Thermo Fisher, MA1-19027) was used in immunoprecipitation on human samples and in western blot on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (W6/32)
  • immunocytochemistry; human
Invitrogen HLA B antibody (eBiosciences, 14-9983-82) was used in immunocytochemistry on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (W6/32)
  • western blot; human
In order to report that the human herpesvirus-7 U21 gene product interferes with natural killer cell recognition, Invitrogen HLA B antibody (Zymed Laboratories, W6/32) was used in western blot on human samples . PLoS Pathog (2011) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human
Invitrogen HLA B antibody (eBioscience, w6/32) was used in flow cytometry on human samples . Nat Immunol (2008) ncbi
Santa Cruz Biotechnology
mouse monoclonal (W6/32)
  • immunohistochemistry; human; 1:200; loading ...; fig 1a
  • western blot; human; 1:200; loading ...; fig s4a
Santa Cruz Biotechnology HLA B antibody (Santa Cruz, sc-32235) was used in immunohistochemistry on human samples at 1:200 (fig 1a) and in western blot on human samples at 1:200 (fig s4a). Nat Commun (2022) ncbi
mouse monoclonal (F-3)
  • western blot; human; loading ...; fig 3b
Santa Cruz Biotechnology HLA B antibody (Santa Cruz, sc-55582) was used in western blot on human samples (fig 3b). Front Immunol (2021) ncbi
mouse monoclonal (LY5.1)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology HLA B antibody (Santa Cruz Biotechnology, sc-52810) was used in western blot on human samples (fig 3a). Oncoimmunology (2018) ncbi
mouse monoclonal (BB7.1)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Santa Cruz Biotechnology HLA B antibody (Santa Cruz Biotechnology, sc-53304) was used in flow cytometry on human samples . F1000Res (2016) ncbi
mouse monoclonal (LY5.1)
  • western blot; human; 1:500; fig 2
Santa Cruz Biotechnology HLA B antibody (Santa Cruz Technologies, SC-52810) was used in western blot on human samples at 1:500 (fig 2). Cancer Res (2015) ncbi
mouse monoclonal (W6/32)
  • western blot; human
Santa Cruz Biotechnology HLA B antibody (Santa Cruz, sc-32235) was used in western blot on human samples . J Virol (2015) ncbi
mouse monoclonal (F-3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
  • western blot; human; fig s4
In order to study T-cell mediated degeneration of catacholaminergic neurons expressing MHC I, Santa Cruz Biotechnology HLA B antibody (Santa Cruz, sc-55582) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1) and in western blot on human samples (fig s4). Nat Commun (2014) ncbi
Bio-Rad
mouse monoclonal (BB7.1)
  • flow cytometry; human; loading ...; fig 1
Bio-Rad HLA B antibody (AbD Serotec/Bio-Rad, MCA986) was used in flow cytometry on human samples (fig 1). J Immunol (2016) ncbi
Miltenyi Biotec
human monoclonal (REA274)
  • flow cytometry; human; loading ...; fig 3a
Miltenyi Biotec HLA B antibody (Miltenyi Biotec, Bw4) was used in flow cytometry on human samples (fig 3a). J Virol (2018) ncbi
BioLegend
mouse monoclonal (BB7.1)
  • flow cytometry; human; loading ...; fig 5b
BioLegend HLA B antibody (Biolegend, BB7.1) was used in flow cytometry on human samples (fig 5b). J Immunol (2016) ncbi
Beckman Coulter
mouse monoclonal (B9.12.1)
  • flow cytometry; human; loading ...
Beckman Coulter HLA B antibody (Immunotech, B9.12.1) was used in flow cytometry on human samples . Front Immunol (2019) ncbi
mouse monoclonal (B9.12.1)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, Beckman Coulter HLA B antibody (Beckman Coulter (Immunotech), B9.12.1) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (B9.12.1)
  • flow cytometry; human; fig 2
Beckman Coulter HLA B antibody (Beckman, B9.12.1) was used in flow cytometry on human samples (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (B9.12.1)
  • flow cytometry; human
Beckman Coulter HLA B antibody (Beckman Coulter, B9.12.1) was used in flow cytometry on human samples . Transpl Immunol (2015) ncbi
MilliporeSigma
mouse monoclonal (W6/32)
  • flow cytometry; human; fig 1a
In order to elucidate the effects of pathogen recognition receptors on dendritic cell maturation, HIV infection, and on the quality of HIV-specific cytotoxic T-cell activation, MilliporeSigma HLA B antibody (Sigma-Aldrich, W6/32) was used in flow cytometry on human samples (fig 1a). Eur J Immunol (2017) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human
  • immunoprecipitation; human
In order to study how Kaposi's sarcoma-associated herpes virus K3 viral gene product decreases cell surface MHC class I, MilliporeSigma HLA B antibody (Sigma-Aldrich, w6/32) was used in flow cytometry on human samples and in immunoprecipitation on human samples . Biochem J (2015) ncbi
mouse monoclonal (W6/32)
  • flow cytometry; human; fig 5
MilliporeSigma HLA B antibody (Sigma, H1650) was used in flow cytometry on human samples (fig 5). J Virol (2014) ncbi
Articles Reviewed
  1. Lei X, Lin H, Wang J, Ou Z, Ruan Y, Sadagopan A, et al. Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression. Nat Commun. 2022;13:3882 pubmed publisher
  2. Lassiter R, Merchen T, Fang X, Wang Y. Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation. Front Immunol. 2021;12:671025 pubmed publisher
  3. Sánchez del Campo L, Martí Díaz R, Montenegro M, González Guerrero R, Hernández Caselles T, Martínez Barba E, et al. MITF induces escape from innate immunity in melanoma. J Exp Clin Cancer Res. 2021;40:117 pubmed publisher
  4. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  5. Li Z, Zhang H, Huang Y, Huang J, Sun P, Zhou N, et al. Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation. Nat Commun. 2020;11:3806 pubmed publisher
  6. Sanz Ortega L, Rojas J, Portilla Y, Pérez Yagüe S, Barber D. Magnetic Nanoparticles Attached to the NK Cell Surface for Tumor Targeting in Adoptive Transfer Therapies Does Not Affect Cellular Effector Functions. Front Immunol. 2019;10:2073 pubmed publisher
  7. Sabol R, Bowles A, Côté A, Wise R, O Donnell B, Matossian M, et al. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Res. 2019;21:67 pubmed publisher
  8. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  9. Luo N, Formisano L, Gonzalez Ericsson P, Sanchez V, Dean P, Opalenik S, et al. Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2. Oncoimmunology. 2018;7:e1438106 pubmed publisher
  10. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  11. Ende Z, Deymier M, Claiborne D, Prince J, Mónaco D, Kilembe W, et al. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs. J Virol. 2018;92: pubmed publisher
  12. Zaikos T, Painter M, Sebastian Kettinger N, Terry V, Collins K. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression. J Virol. 2018;92: pubmed publisher
  13. Tong A, Hashem H, Eid S, Allen F, Kingsley D, Huang A. Adoptive natural killer cell therapy is effective in reducing pulmonary metastasis of Ewing sarcoma. Oncoimmunology. 2017;6:e1303586 pubmed publisher
  14. Seif M, Hoppstädter J, Breinig F, Kiemer A. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm. 2017;117:1-13 pubmed publisher
  15. Cardinaud S, Urrutia A, Rouers A, Coulon P, Kervevan J, Richetta C, et al. Triggering of TLR-3, -4, NOD2, and DC-SIGN reduces viral replication and increases T-cell activation capacity of HIV-infected human dendritic cells. Eur J Immunol. 2017;47:818-829 pubmed publisher
  16. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  17. Uruha A, Nishikawa A, Tsuburaya R, Hamanaka K, Kuwana M, Watanabe Y, et al. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis. Neurology. 2017;88:493-500 pubmed publisher
  18. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  19. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  20. Dellgren C, Ekwelum V, Ormhøj M, Pallesen N, Knudsen J, Nehlin J, et al. Low Constitutive Cell Surface Expression of HLA-B Is Caused by a Posttranslational Mechanism Involving Glu180 and Arg239. J Immunol. 2016;197:4807-4816 pubmed
  21. Huang M, Zhang W, Guo J, Wei X, Phiwpan K, Zhang J, et al. Improved Transgenic Mouse Model for Studying HLA Class I Antigen Presentation. Sci Rep. 2016;6:33612 pubmed publisher
  22. Seif M, Philippi A, Breinig F, Kiemer A, Hoppstädter J. Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype. Inflammation. 2016;39:1690-703 pubmed publisher
  23. Zhang R, Miner J, Gorman M, Rausch K, Ramage H, White J, et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature. 2016;535:164-8 pubmed
  24. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  25. Reches A, Nachmani D, Berhani O, Duev Cohen A, Shreibman D, Ophir Y, et al. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins. J Immunol. 2016;196:4967-76 pubmed publisher
  26. Uruha A, Noguchi S, Hayashi Y, Tsuburaya R, Yonekawa T, Nonaka I, et al. Hepatitis C virus infection in inclusion body myositis: A case-control study. Neurology. 2016;86:211-7 pubmed publisher
  27. Parkinson M, Piper S, Bright N, Evans J, Boname J, Bowers K, et al. A non-canonical ESCRT pathway, including histidine domain phosphotyrosine phosphatase (HD-PTP), is used for down-regulation of virally ubiquitinated MHC class I. Biochem J. 2015;471:79-88 pubmed publisher
  28. Miranda A, Funes J, Sánchez N, Limia C, Mesa M, Quezada S, et al. Oncogenic Transformation Can Orchestrate Immune Evasion and Inflammation in Human Mesenchymal Stem Cells Independently of Extrinsic Immune-Selective Pressure. Cancer Res. 2015;75:3032-42 pubmed publisher
  29. Guo X, Liu T, Shi H, Wang J, Ji P, Wang H, et al. Respiratory Syncytial Virus Infection Upregulates NLRC5 and Major Histocompatibility Complex Class I Expression through RIG-I Induction in Airway Epithelial Cells. J Virol. 2015;89:7636-45 pubmed publisher
  30. Esquivel E, Maeda A, Eguchi H, Asada M, Sugiyama M, Manabe C, et al. Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G. Transpl Immunol. 2015;32:109-15 pubmed publisher
  31. Gabaev I, Elbasani E, Ameres S, Steinbrück L, Stanton R, Döring M, et al. Expression of the human cytomegalovirus UL11 glycoprotein in viral infection and evaluation of its effect on virus-specific CD8 T cells. J Virol. 2014;88:14326-39 pubmed publisher
  32. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Karbach J, et al. Immunomodulatory action of SGI-110, a hypomethylating agent, in acute myeloid leukemia cells and xenografts. Leuk Res. 2014;38:1332-41 pubmed publisher
  33. Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE. 2014;9:e104692 pubmed publisher
  34. Arellano Garcia M, Misuno K, Tran S, Hu S. Interferon-? induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells. PLoS ONE. 2014;9:e102878 pubmed publisher
  35. Cebrián C, Zucca F, Mauri P, Steinbeck J, Studer L, Scherzer C, et al. MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration. Nat Commun. 2014;5:3633 pubmed publisher
  36. Stahlschmidt W, Robertson M, Robinson P, McCluskey A, Haucke V. Clathrin terminal domain-ligand interactions regulate sorting of mannose 6-phosphate receptors mediated by AP-1 and GGA adaptors. J Biol Chem. 2014;289:4906-18 pubmed publisher
  37. Schneider C, Hudson A. The human herpesvirus-7 (HHV-7) U21 immunoevasin subverts NK-mediated cytoxicity through modulation of MICA and MICB. PLoS Pathog. 2011;7:e1002362 pubmed publisher
  38. Di Pucchio T, Chatterjee B, Smed Sorensen A, Clayton S, Palazzo A, Montes M, et al. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol. 2008;9:551-7 pubmed publisher